Eli Lilly and (LLY) Stock Insights
LLY$1,293.37+11.46 +0.89%
$1.22T
Market Cap
42.89
P/E
38.12
Forward P/E
54
Score
Eli Lilly and (LLY) Stock Insights
LLY price $1,293.37 +11.46 +0.89%
- Ticker
- LLY
- Price
- $1,293.37
- Change
- +11.46 +0.89%
- Market cap ?
- $1.22T
- P/E ?
- 42.89
- Forward P/E ?
- 38.12
- Dividend yield ?
- 0.52%
- Beta ?
- 0.45
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 54
- Value
- 18
- Quality
- 73
- Growth
- 71
Stocklytics score rationale: value 18, quality 73, growth 71.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 21222100000 | 19973800000 | 21493300000 | 22319500000 | 24539800000 | 28318400000 | 28541400000 | 34124100000 | 45043000000 | 65179000000 |
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and…
Fair value
LLY fair value $1,300.91. Price $1,293.37. Price is about fair value.
Above fair value, but less expensive than usual. A smaller premium than on 86% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 20.05B. Growth 18.81%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 941.36M. Net debt 35.34B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | 5.68 | — | 22.58B |
| 2026-08-05 | 8.38 | 6.40 | 22.97B | 20.82B |
| 2026-04-30 | 8.55 | 6.97 | 19.80B | 17.82B |
| 2026-02-04 | 7.54 | 6.91 | 19.29B | 17.94B |
| 2025-10-30 | 7.02 | 5.69 | 17.60B | 16.05B |
| 2025-08-07 | 6.31 | 5.60 | 15.56B | 14.70B |
| 2025-05-01 | 3.34 | 3.26 | 12.73B | 12.67B |
| 2025-02-06 | 5.32 | 5.03 | 13.53B | — |
| 2024-10-30 | 1.18 | 1.47 | 11.44B | 12.10B |
| 2024-08-08 | 3.92 | 2.60 | 11.30B | 9.98B |
| 2024-04-30 | 2.58 | 2.46 | 8.77B | 8.94B |
| 2024-02-06 | 2.49 | 2.22 | 9.35B | 8.93B |
| 2023-11-02 | 0.10 | -0.08 | 9.50B | 8.95B |
| 2023-08-08 | 2.11 | 1.98 | 8.31B | 7.58B |
| 2023-04-27 | 1.62 | 1.73 | 6.96B | 7.55B |
| 2023-02-02 | 2.09 | 1.78 | 7.30B | 7.33B |
| 2022-11-01 | 1.98 | 1.92 | 6.94B | 6.89B |
| 2022-08-04 | 1.25 | 1.69 | 6.49B | 6.85B |
| 2022-04-28 | 2.62 | 2.32 | 7.81B | 7.29B |
| 2022-02-03 | 2.49 | 2.51 | 8.00B | 7.69B |
| 2021-10-26 | 1.94 | 1.98 | 6.77B | 6.57B |
| 2021-08-03 | 1.87 | 1.89 | 6.74B | 6.74B |
| 2021-04-27 | 1.87 | 2.12 | 6.81B | 7.64B |
| 2021-01-29 | 2.75 | 2.35 | 7.44B | 6.17B |
| 2020-10-27 | 1.54 | 1.71 | 5.74B | 6.37B |
| 2020-07-30 | 1.89 | 1.56 | 5.50B | 4.54B |
| 2020-04-23 | 1.75 | 1.48 | 5.86B | 4.96B |
| 2020-01-30 | 1.73 | 1.52 | 6.11B | 5.37B |
| 2019-10-23 | 1.48 | 1.41 | 5.48B | 5.22B |
| 2019-07-30 | 1.50 | 1.45 | 5.64B | 5.45B |
| 2019-04-30 | 1.33 | 1.32 | 5.09B | 5.02B |
| 2019-02-06 | 1.33 | 1.34 | 6.44B | 5.68B |
| 2018-11-06 | 1.39 | 1.35 | 5.31B | 5.15B |
| 2018-07-24 | 1.50 | 1.31 | 5.58B | 4.84B |
| 2018-04-24 | 1.34 | 1.13 | 4.96B | 4.19B |
| 2018-01-31 | 1.14 | 1.08 | 6.16B | 5.78B |
| 2017-10-24 | 1.05 | 1.03 | 5.66B | 5.55B |
| 2017-07-25 | 1.11 | 1.05 | 5.82B | 5.51B |
| 2017-04-25 | 0.98 | 0.96 | 5.23B | 5.12B |
| 2017-01-31 | 0.95 | 0.99 | 5.76B | 5.94B |
Dividends
Yield 0.52%. Payout ratio 21.66%. Frequency Quarterly.
Safety score 91/100 · Safe. Payout ratio is 22% of earnings. Dividends use less than 40% of free cash flow. Dividends were paid in 55 separate years. Yield is 0.5%, which is modest.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-11-13 | $1.73 | 2026-11-13 | 2026-12-10 | Quarterly |
| 2026-08-14 | $1.73 | 2026-08-14 | 2026-09-10 | Quarterly |
| 2026-05-15 | $1.73 | 2026-05-15 | 2026-06-10 | Quarterly |
| 2026-02-13 | $1.73 | 2026-02-13 | 2026-03-10 | Quarterly |
| 2025-11-14 | $1.50 | 2025-11-14 | 2025-12-10 | Quarterly |
| 2025-08-15 | $1.50 | 2025-08-15 | 2025-09-10 | Quarterly |
| 2025-05-16 | $1.50 | 2025-05-16 | 2025-06-10 | Quarterly |
| 2025-02-14 | $1.50 | 2025-02-14 | 2025-03-10 | Quarterly |
| 2024-11-15 | $1.30 | 2024-11-15 | 2024-12-10 | Quarterly |
| 2024-08-15 | $1.30 | 2024-08-15 | 2024-09-10 | Quarterly |
| 2024-05-15 | $1.30 | 2024-05-16 | 2024-06-10 | Quarterly |
| 2024-02-14 | $1.30 | 2024-02-15 | 2024-03-08 | Quarterly |
| 2023-11-14 | $1.13 | 2023-11-15 | 2023-12-08 | Quarterly |
| 2023-08-14 | $1.13 | 2023-08-15 | 2023-09-08 | Quarterly |
| 2023-05-12 | $1.13 | 2023-05-15 | 2023-06-09 | Quarterly |
| 2023-02-14 | $1.13 | 2023-02-15 | 2023-03-10 | Quarterly |
| 2022-11-14 | $0.98 | 2022-11-15 | 2022-12-09 | Quarterly |
| 2022-08-12 | $0.98 | 2022-08-15 | 2022-09-09 | Quarterly |
| 2022-05-13 | $0.98 | 2022-05-16 | 2022-06-10 | Quarterly |
| 2022-02-14 | $0.98 | 2022-02-15 | 2022-03-10 | Quarterly |
| 2021-11-12 | $0.85 | 2021-11-15 | 2021-12-10 | Quarterly |
| 2021-08-12 | $0.85 | 2021-08-13 | 2021-09-10 | Quarterly |
| 2021-05-13 | $0.85 | 2021-05-14 | 2021-06-10 | Quarterly |
| 2021-02-11 | $0.85 | 2021-02-12 | 2021-03-10 | Quarterly |
| 2020-11-12 | $0.74 | 2020-11-13 | 2020-12-10 | Quarterly |
| 2020-08-13 | $0.74 | 2020-08-14 | 2020-09-10 | Quarterly |
| 2020-05-14 | $0.74 | 2020-05-15 | 2020-06-10 | Quarterly |
| 2020-02-13 | $0.74 | 2020-02-14 | 2020-03-10 | Quarterly |
| 2019-11-14 | $0.65 | 2019-11-15 | 2019-12-10 | Quarterly |
| 2019-08-14 | $0.65 | 2019-08-15 | 2019-09-10 | Quarterly |
| 2019-05-16 | $0.65 | 2019-05-17 | 2019-06-10 | Quarterly |
| 2019-02-14 | $0.65 | 2019-02-15 | 2019-03-08 | Quarterly |
| 2018-11-14 | $0.56 | 2018-11-15 | 2018-12-10 | Quarterly |
| 2018-08-14 | $0.56 | 2018-08-15 | 2018-09-10 | Quarterly |
| 2018-05-16 | $0.56 | 2018-05-17 | 2018-06-08 | Quarterly |
| 2018-02-14 | $0.56 | 2018-02-15 | 2018-03-09 | Quarterly |
| 2017-11-14 | $0.52 | 2017-11-15 | 2017-12-08 | Quarterly |
| 2017-08-11 | $0.52 | 2017-08-15 | 2017-09-08 | Quarterly |
| 2017-05-11 | $0.52 | 2017-05-15 | 2017-06-09 | Quarterly |
| 2017-02-13 | $0.52 | 2017-02-15 | 2017-03-10 | Quarterly |
| 2016-11-10 | $0.51 | 2016-11-15 | 2016-12-09 | Quarterly |
| 2016-08-11 | $0.51 | 2016-08-15 | 2016-09-09 | Quarterly |
| 2016-05-11 | $0.51 | 2016-05-13 | 2016-06-10 | Quarterly |
| 2016-02-10 | $0.51 | 2016-02-12 | 2016-03-10 | Quarterly |
| 2015-11-10 | $0.50 | 2015-11-13 | 2015-12-10 | Quarterly |
| 2015-08-12 | $0.50 | 2015-08-14 | 2015-09-10 | Quarterly |
| 2015-05-14 | $0.50 | 2015-05-18 | 2015-06-10 | Quarterly |
| 2015-02-11 | $0.50 | 2015-02-13 | 2015-03-10 | Quarterly |
| 2014-11-12 | $0.49 | 2014-11-14 | 2014-12-10 | Quarterly |
| 2014-08-13 | $0.49 | 2014-08-15 | 2014-09-10 | Quarterly |
| 2014-05-13 | $0.49 | 2014-05-15 | 2014-06-10 | Quarterly |
| 2014-02-12 | $0.49 | 2014-02-14 | 2014-03-10 | Quarterly |
| 2013-11-13 | $0.49 | 2013-11-15 | 2013-12-10 | Quarterly |
| 2013-08-13 | $0.49 | 2013-08-15 | 2013-09-10 | Quarterly |
| 2013-05-14 | $0.49 | 2013-05-16 | 2013-06-10 | Quarterly |
| 2013-02-13 | $0.49 | 2013-02-15 | 2013-03-08 | Quarterly |
| 2012-11-13 | $0.49 | 2012-11-15 | 2012-12-10 | Quarterly |
| 2012-08-13 | $0.49 | 2012-08-15 | 2012-09-10 | Quarterly |
| 2012-05-11 | $0.49 | 2012-05-15 | 2012-06-08 | Quarterly |
| 2012-02-13 | $0.49 | 2012-02-15 | 2012-03-09 | Quarterly |
| 2011-11-10 | $0.49 | 2011-11-15 | 2011-12-09 | Quarterly |
| 2011-08-11 | $0.49 | 2011-08-15 | 2011-09-09 | Quarterly |
| 2011-05-11 | $0.49 | 2011-05-13 | 2011-06-10 | Quarterly |
| 2011-02-11 | $0.49 | 2011-02-15 | 2011-03-10 | Quarterly |
| 2010-11-10 | $0.49 | 2010-11-15 | 2010-12-10 | Quarterly |
| 2010-08-11 | $0.49 | 2010-08-13 | 2010-09-10 | Quarterly |
| 2010-05-12 | $0.49 | 2010-05-14 | 2010-06-10 | Quarterly |
| 2010-02-10 | $0.49 | 2010-02-12 | 2010-03-10 | Quarterly |
| 2009-11-10 | $0.49 | 2009-11-13 | 2009-12-10 | Quarterly |
| 2009-08-12 | $0.49 | 2009-08-15 | 2009-09-10 | Quarterly |
| 2009-05-13 | $0.49 | 2009-05-15 | 2009-06-10 | Quarterly |
| 2009-02-11 | $0.49 | 2009-02-13 | 2009-03-10 | Quarterly |
| 2008-11-12 | $0.47 | 2008-11-14 | 2008-12-10 | Quarterly |
| 2008-08-13 | $0.47 | 2008-08-15 | 2008-09-10 | Quarterly |
| 2008-05-13 | $0.47 | 2008-05-15 | 2008-06-10 | Quarterly |
| 2008-02-13 | $0.47 | 2008-02-15 | 2008-03-10 | Quarterly |
| 2007-11-13 | $0.42 | 2007-11-15 | 2007-12-10 | Quarterly |
| 2007-08-13 | $0.42 | 2007-08-15 | 2007-09-10 | Quarterly |
| 2007-05-11 | $0.42 | 2007-05-15 | 2007-06-08 | Quarterly |
| 2007-02-13 | $0.42 | 2007-02-15 | 2007-03-09 | Quarterly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2028-02-16 | Brown Adrienne S | Other | 354 | — | — |
| 2026-10-19 | Sulzberger Gabrielle | Buy | 4 | $1,240.34 | 4.96K |
| 2026-10-19 | LUCIANO JUAN R | Buy | 13 | $1,240.34 | 15.92K |
| 2026-10-19 | Fyrwald J Erik | Buy | 8 | $1,240.34 | 9.92K |
| 2026-10-19 | Alvarez Ralph | Buy | 10 | $1,240.34 | 12.42K |
| 2026-09-21 | Sulzberger Gabrielle | Buy | 4 | $1,164.89 | 4.96K |
| 2026-09-21 | LUCIANO JUAN R | Buy | 14 | $1,164.89 | 15.92K |
| 2026-09-21 | Fyrwald J Erik | Buy | 9 | $1,164.89 | 9.92K |
| 2026-09-21 | Alvarez Ralph | Buy | 11 | $1,164.89 | 12.42K |
| 2026-09-09 | Seymour Melissa | Sell | 12 | — | — |
| 2026-09-02 | Hernandez Edgardo | Sell | 13 | — | — |
| 2026-09-02 | Dozier Eric | Sell | 216 | — | — |
| 2026-08-17 | Sulzberger Gabrielle | Buy | 4 | $1,183.16 | 4.96K |
| 2026-08-17 | LUCIANO JUAN R | Buy | 13 | $1,183.16 | 15.92K |
| 2026-08-17 | Fyrwald J Erik | Buy | 8 | $1,183.16 | 9.92K |
| 2026-08-17 | Alvarez Ralph | Buy | 10 | $1,183.16 | 12.42K |
| 2026-08-17 | Jonsson Patrik | Sell | 6.50K | $1,175.10 | 7.64M |
| 2026-08-10 | Zakrowski Donald A | Sell | 2.00K | $1,185.01 | 2.37M |
| 2026-08-07 | Hakim Anat | Sell | 5.00K | $1,190.00 | 5.95M |
| 2026-08-01 | Seymour Melissa | Buy | 981 | — | — |
| 2026-08-01 | Seymour Melissa | Sell | 439 | $1,148.84 | 504.00K |
| 2026-08-01 | Seymour Melissa | Sell | 981 | — | — |
| 2026-07-20 | Sulzberger Gabrielle | Buy | 4 | $1,146.90 | 4.96K |
| 2026-07-20 | LUCIANO JUAN R | Buy | 14 | $1,146.90 | 15.92K |
| 2026-07-20 | Fyrwald J Erik | Buy | 9 | $1,146.90 | 9.92K |
| 2026-07-20 | Alvarez Ralph | Buy | 11 | $1,146.90 | 12.42K |
| 2026-06-15 | Sulzberger Gabrielle | Buy | 4 | $1,129.35 | 4.96K |
| 2026-06-15 | LUCIANO JUAN R | Buy | 14 | $1,129.35 | 15.92K |
| 2026-06-15 | Fyrwald J Erik | Buy | 9 | $1,129.35 | 9.92K |
| 2026-06-15 | Alvarez Ralph | Buy | 11 | $1,129.35 | 12.42K |
| 2026-06-10 | Yuffa Ilya | Sell | 2.50K | $1,150.77 | 2.88M |
| 2026-05-18 | Sulzberger Gabrielle | Buy | 5 | $988.09 | 4.96K |
| 2026-05-18 | LUCIANO JUAN R | Buy | 16 | $988.09 | 15.92K |
| 2026-05-18 | Fyrwald J Erik | Buy | 10 | $988.09 | 9.92K |
| 2026-05-18 | Alvarez Ralph | Buy | 13 | $988.09 | 12.42K |
| 2026-05-06 | LILLY ENDOWMENT INC | Sell | 13.62K | $995.23 | 13.55M |
| 2026-05-06 | LILLY ENDOWMENT INC | Sell | 2.21K | $996.18 | 2.20M |
| 2026-04-20 | Sulzberger Gabrielle | Buy | 5 | $919.90 | 4.96K |
| 2026-04-20 | LUCIANO JUAN R | Buy | 17 | $919.90 | 15.92K |
| 2026-04-20 | Fyrwald J Erik | Buy | 11 | $919.90 | 9.92K |
| 2026-04-20 | Alvarez Ralph | Buy | 13 | $919.90 | 12.42K |
| 2026-03-16 | Sulzberger Gabrielle | Buy | 5 | $989.12 | 4.96K |
| 2026-03-16 | LUCIANO JUAN R | Buy | 16 | $989.12 | 15.92K |
| 2026-03-16 | Fyrwald J Erik | Buy | 10 | $989.12 | 9.92K |
| 2026-03-16 | Alvarez Ralph | Buy | 13 | $989.12 | 12.42K |
| 2026-02-19 | Dozier Eric | Sell | 481 | — | — |
| 2026-02-17 | Sulzberger Gabrielle | Buy | 5 | $1,036.05 | 4.96K |
| 2026-02-17 | LUCIANO JUAN R | Buy | 15 | $1,036.05 | 15.92K |
| 2026-02-17 | Fyrwald J Erik | Buy | 10 | $1,036.05 | 9.92K |
| 2026-02-17 | Alvarez Ralph | Buy | 12 | $1,036.05 | 12.42K |
| 2026-02-16 | Zakrowski Donald A | Buy | 184 | — | — |
| 2026-02-16 | Zakrowski Donald A | Sell | 82 | $1,040.00 | 84.82K |
| 2026-02-16 | Zakrowski Donald A | Sell | 184 | — | — |
| 2026-02-16 | Montarce Lucas | Buy | 368 | — | — |
| 2026-02-16 | Montarce Lucas | Sell | 160 | $1,040.00 | 166.12K |
| 2026-02-16 | Montarce Lucas | Sell | 368 | — | — |
| 2026-02-16 | Custer Kenneth L. | Buy | 207 | — | — |
| 2026-02-16 | Custer Kenneth L. | Sell | 91 | $1,040.00 | 94.96K |
| 2026-02-16 | Custer Kenneth L. | Sell | 207 | — | — |
| 2026-02-16 | Brown Adrienne S | Buy | 391 | — | — |
| 2026-02-16 | Brown Adrienne S | Sell | 170 | $1,040.00 | 176.76K |
| 2026-02-16 | Brown Adrienne S | Sell | 391 | — | — |
| 2026-02-09 | Rau Diogo | Buy | 4.60K | $1,044.67 | 4.80M |
| 2026-02-09 | Zakrowski Donald A | Buy | 584 | $1,044.67 | 609.86K |
| 2026-02-09 | Zakrowski Donald A | Buy | 199 | — | — |
| 2026-02-09 | Yuffa Ilya | Buy | 4.16K | $1,044.67 | 4.35M |
| 2026-02-09 | Van Naarden Jacob | Buy | 4.87K | $1,044.67 | 5.08M |
| 2026-02-09 | Skovronsky Daniel | Buy | 15.55K | $1,044.67 | 16.24M |
| 2026-02-09 | Ricks David A | Buy | 38.91K | $1,044.67 | 40.65M |
| 2026-02-09 | Rau Diogo | Buy | 4.43K | $1,044.67 | 4.63M |
| 2026-02-09 | Montarce Lucas | Buy | 1.37K | $1,044.67 | 1.43M |
| 2026-02-09 | Jonsson Patrik | Buy | 4.82K | $1,044.67 | 5.03M |
| 2026-02-09 | Hernandez Edgardo | Buy | 4.38K | $1,044.67 | 4.58M |
| 2026-02-09 | Hakim Anat | Buy | 8.28K | $1,044.67 | 8.65M |
| 2026-02-09 | Dozier Eric | Buy | 3.51K | $1,044.67 | 3.67M |
| 2026-02-09 | Custer Kenneth L. | Buy | 659 | $1,044.67 | 688.73K |
| 2026-02-09 | Brown Adrienne S | Buy | 1.20K | $1,044.67 | 1.25M |
| 2026-02-01 | Yuffa Ilya | Buy | 3.39K | — | — |
| 2026-02-01 | Yuffa Ilya | Sell | 1.51K | $1,037.15 | 1.57M |
| 2026-02-01 | Yuffa Ilya | Sell | 3.39K | — | — |
| 2026-02-01 | Skovronsky Daniel | Buy | 12.68K | — | — |
| 2026-02-01 | Skovronsky Daniel | Sell | 5.64K | $1,037.15 | 5.85M |
| 2026-02-01 | Skovronsky Daniel | Sell | 12.68K | — | — |
| 2026-02-01 | Van Naarden Jacob | Buy | 4.11K | — | — |
| 2026-02-01 | Van Naarden Jacob | Sell | 1.91K | $1,037.15 | 1.98M |
| 2026-02-01 | Van Naarden Jacob | Sell | 4.11K | — | — |
| 2026-02-01 | Ricks David A | Buy | 31.93K | — | — |
| 2026-02-01 | Ricks David A | Sell | 14.30K | $1,037.15 | 14.83M |
| 2026-02-01 | Ricks David A | Sell | 31.93K | — | — |
| 2026-02-01 | Rau Diogo | Buy | 3.75K | — | — |
| 2026-02-01 | Rau Diogo | Sell | 1.67K | $1,037.15 | 1.74M |
| 2026-02-01 | Rau Diogo | Sell | 3.75K | — | — |
| 2026-02-01 | Jonsson Patrik | Buy | 3.93K | — | — |
| 2026-02-01 | Jonsson Patrik | Sell | 1.75K | $1,037.15 | 1.82M |
| 2026-02-01 | Jonsson Patrik | Sell | 3.93K | — | — |
| 2026-02-01 | Hernandez Edgardo | Buy | 3.57K | — | — |
| 2026-02-01 | Hernandez Edgardo | Sell | 1.59K | $1,037.15 | 1.65M |
| 2026-02-01 | Hernandez Edgardo | Sell | 3.57K | — | — |
| 2026-02-01 | Hakim Anat | Buy | 6.70K | — | — |
| 2026-02-01 | Hakim Anat | Sell | 2.95K | $1,037.15 | 3.06M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 4.80K, holders +274 vs prior quarter. Ownership 88.92%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| LILLY ENDOWMENT INC | 90.38M | -1.52M | -1.65% | 108.40B |
| BLACKROCK, INC. | 67.54M | 1.16M | +1.75% | 81.01B |
| VANGUARD CAPITAL MANAGEMENT LLC | 53.53M | 167.09K | +0.31% | 64.20B |
| PNC FINANCIAL SERVICES GROUP, INC. | 51.32M | -6.19K | -0.01% | 61.56B |
| STATE STREET CORP | 36.22M | 605.75K | +1.70% | 43.44B |
| FMR LLC | 28.46M | 2.12M | +8.05% | 34.14B |
| CAPITAL RESEARCH GLOBAL INVESTORS | 20.87M | -3.76M | -15.26% | 25.04B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 20.86M | -117.81K | -0.56% | 25.02B |
| GEODE CAPITAL MANAGEMENT, LLC | 20.31M | 118.99K | +0.59% | 24.28B |
| MORGAN STANLEY | 16.23M | 788.94K | +5.11% | 19.46B |
| CAPITAL WORLD INVESTORS | 15.90M | 280.83K | +1.80% | 19.08B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 13.91M | -80.39K | -0.57% | 16.69B |
| JPMORGAN CHASE & CO | 12.60M | -1.10M | -8.03% | 15.50B |
| NORGES BANK | 11.47M | 11.47M | New | 13.76B |
| BANK OF AMERICA CORP /DE/ | 11.27M | 148.41K | +1.33% | 13.52B |
| WELLINGTON MANAGEMENT GROUP LLP | 11.00M | -2.43M | -18.08% | 13.19B |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 10.76M | 0 | 0.00% | 12.90B |
| PRIMECAP MANAGEMENT CO/CA/ | 9.17M | -50.53K | -0.55% | 11.00B |
| NORTHERN TRUST CORP | 8.80M | -30.70K | -0.35% | 10.55B |
| GOLDMAN SACHS GROUP INC | 7.65M | 1.31M | +20.69% | 9.18B |
| UBS GROUP AG | 7.30M | 3.26M | +80.54% | 8.76B |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 7.21M | 137.36K | +1.94% | 8.65B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 6.00M | 104.50K | +1.77% | 7.20B |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 6.00M | 6.00M | New | 7.20B |
| CAPITAL INTERNATIONAL INVESTORS | 5.73M | -381.92K | -6.24% | 6.88B |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2011 | Animal Health Products: 681700000.0, Human Pharmaceutical Products: 23604800000.0 |
| FY2012 | Animal Health Products: 2036500000.0, Cardiovascular: 2632500000.0, Endocrinology: 6810900000.0, Neuroscience: 7575100000.0, Oncology: 3281600000.0 |
| FY2013 | Animal Health Products: 2151500000.0, Cardiovascular: 2923200000.0, Endocrinology: 7304400000.0, Neuroscience: 7216200000.0, Oncology: 3268500000.0, Other Pharmaceuticals: 249300000.0 |
| FY2014 | Animal Health Products: 2346600000.0, Cardiovascular: 3053500000.0, Endocrinology: 6939000000.0, Neuroscience: 3596500000.0, Oncology: 3393000000.0 |
| FY2015 | Animal Health Products: 3181000000.0, Cardiovascular: 3068000000.0, Endocrinology: 7036800000.0, Neuroscience: 2935400000.0, Oncology: 3509800000.0 |
| FY2016 | Animal Health Products: 3158200000.0, Human Pharmaceutical Products: 18063900000.0 |
| FY2017 | Animal Health Products: 3085600000.0, Human Pharmaceutical Products: 19785700000.0 |
| FY2018 | Animal Health Products: 1619500000.0, Human Pharmaceutical Products: 12352200000.0 |
| FY2019 | Collaboration and Other Revenue: 1942200000.0, Product: 20377300000.0 |
| FY2020 | Collaboration and Other Revenue: 1845000000.0, Product: 22694800000.0 |
| FY2021 | Collaboration and Other Revenue: 2360500000.0, Product: 25957900000.0 |
| FY2022 | Collaboration and Other Revenue: 3078600000.0, Product: 25462800000.0 |
| FY2023 | Collaboration and Other Revenue: 5310200000.0, Product: 28813900000.0 |
| FY2024 | Collaboration and Other Revenue: 4294800000.0, Product: 40747900000.0 |
| FY2025 | Collaboration and Other Revenue: 4221000000.0, Product: 60958000000.0 |
| Period | Value |
|---|---|
| FY2012 | Europe: 4259700000.0, JAPAN: 2246200000.0, Non-US: 3784400000.0, UNITED STATES: 12313100000.0 |
| FY2013 | Animal Health Products: 2151500000.0, Cardiovascular: 2923200000.0, Endocrinology: 7304400000.0, Neuroscience: 7216200000.0, Oncology: 3268500000.0, Other Pharmaceuticals: 249300000.0 |
| FY2014 | Europe: 4506700000.0, JAPAN: 2027100000.0, Other Foreign Countries: 3947700000.0, UNITED STATES: 9134100000.0 |
| FY2015 | Europe: 3943600000.0, JAPAN: 2033100000.0, Other Foreign Countries: 3884600000.0, UNITED STATES: 10097400000.0 |
| FY2016 | Europe: 3768100000.0, JAPAN: 2330900000.0, Non-US: 3616900000.0, UNITED STATES: 11506200000.0 |
| FY2017 | Europe: 3943200000.0, JAPAN: 2419700000.0, Non-US: 3723300000.0, UNITED STATES: 12785100000.0 |
| FY2018 | Europe: 4231100000.0, JAPAN: 2493700000.0, Non-US: 14636200000.0 |
| FY2019 | Europe: 3765000000.0, JAPAN: 2547600000.0, Other Foreign Countries: 3284300000.0, UNITED STATES: 12722600000.0 |
| FY2020 | CHINA: 1116900000.0, Europe: 4187700000.0, JAPAN: 2583100000.0, Other Foreign Countries: 2422700000.0, UNITED STATES: 14229300000.0 |
| FY2021 | CHINA: 1661400000.0, Europe: 4776800000.0, JAPAN: 2367000000.0, Non-US: 2702200000.0, UNITED STATES: 16811000000.0 |
| FY2022 | CHINA: 1452800000.0, Europe: 4299200000.0, JAPAN: 1747300000.0, Non-US: 2852000000.0, UNITED STATES: 18190000000.0 |
| FY2023 | CHINA: 1539700000.0, Europe: 6174700000.0, JAPAN: 1672600000.0, Non-US: 2946200000.0, UNITED STATES: 21791000000.0 |
| FY2024 | CHINA: 1660400000.0, Europe: 6920700000.0, JAPAN: 1814900000.0, Non-US: 4271400000.0, UNITED STATES: 30375200000.0 |
| FY2025 | CHINA: 1951000000.0, Europe: 11558000000.0, JAPAN: 2132000000.0, Non-US: 6057000000.0, UNITED STATES: 43481000000.0 |
Insights · Dividends · Forecast · Financials · Learn